General information about company | ||
| Scrip code | 544122 | |
| NSE Symbol | ENTERO | |
| MSEI Symbol | NOTLISTED | |
| ISIN | INE010601016 | |
| Name of the entity | Entero Healthcare Solutions Limited | |
| Date of start of financial year | 01-04-2025 | |
| Date of end of financial year | 31-03-2026 | |
| Reporting Quarter Type | Quarterly | |
| Date of Quarter Ending | 30-06-2025 | |
| Type of company | Equity | |
| Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? | Yes | |
| Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? | Yes | |
| Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? | Yes | |
| Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? | Yes | |
| Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? | Yes | |
| Risk management committee | Applicable | |
| Market Capitalisation as per immediate previous Financial Year | Top 1000 listed entities | |
| Is SCORE ID Available ? | Yes | |
| SCORE Registration ID | COME00400 | |
| Reason For No SCORE ID | ||
| Type of Submission | Original | |
| Remarks (website dissemination) | ||
| Remarks for Exchange (not for Website Dissemination) | ||
Annexure I | |||||||||||||||||||||||||
Annexure I to be submitted by listed entity on quarterly basis | |||||||||||||||||||||||||
I. Composition of Board of Directors | |||||||||||||||||||||||||
| Disclosure of notes on composition of board of directors explanatory | Textual Information(1) | ||||||||||||||||||||||||
| Whether the listed entity has a Regular Chairperson | Yes | ||||||||||||||||||||||||
| Whether Chairperson is related to MD or CEO | No | ||||||||||||||||||||||||
| Sr | Title (Mr / Ms) | Name of the Director | PAN | DIN | Category 1 of directors | Category 2 of directors | Category 3 of directors | Date of Birth | |||||||||||||||||
| 1 | Mr | VASUDEVAN SUJESH | AFVPS4486A | 08240092 | Non-Executive - Independent Director | Chairperson | 01-10-1965 | ||||||||||||||||||
| 2 | Ms | SANDHYA GADKARI SHARMA | AGTPS3153K | 02005378 | Non-Executive - Independent Director | Not Applicable | 26-10-1960 | ||||||||||||||||||
| 3 | Mr | RAJESH SHASHIKANT DALAL | AARPD5462C | 03504969 | Non-Executive - Independent Director | Not Applicable | 12-09-1953 | ||||||||||||||||||
| 4 | Mr | ARUN SADHANANDHAM | BUYPS5030F | 08445197 | Non-Executive - Nominee Director | Not Applicable | 23-09-1984 | ||||||||||||||||||
| 5 | Ms | SUMONA CHAKRABORTY | AHYPC4921H | 09597426 | Non-Executive - Nominee Director | Not Applicable | 10-01-1988 | ||||||||||||||||||
| 6 | Mr | PRABHAT AGRAWAL | ACDPA2430P | 07466382 | Executive Director | Not Applicable | CEO-MD | 24-01-1977 | |||||||||||||||||
| 7 | Mr | PREM SETHI | ALGPS5647C | 07077034 | Executive Director | Not Applicable | 28-06-1977 | ||||||||||||||||||
| 8 | Mr | KEVIN ROHITBHAI DAFTARY | AIGPD1523K | 10637792 | Non-Executive - Nominee Director | Not Applicable | 30-12-1982 | ||||||||||||||||||
I. Composition of Board of Directors | |||||||||||||||||||||||||
Disqualification of Directors under section 164 of the Companies Act, 2013 | |||||||||||||||||||||||||
| Sr | Whether the director is disqualified? | Start Date of disqualification | End Date of disqualification | Details of disqualification | Current status | ||||||||||||||||||||
| 1 | No | Active | |||||||||||||||||||||||
| 2 | No | Active | |||||||||||||||||||||||
| 3 | No | Active | |||||||||||||||||||||||
| 4 | No | Active | |||||||||||||||||||||||
| 5 | No | Active | |||||||||||||||||||||||
| 6 | No | Active | |||||||||||||||||||||||
| 7 | No | Active | |||||||||||||||||||||||
| 8 | No | Active | |||||||||||||||||||||||
I. Composition of Board of Directors | |||||||||||||||||||||||||||
| Sr | Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] | Date of passing special resolution | Initial Date of appointment | Date of Re-appointment | Date of cessation | Tenure of director (in months) | No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) | No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & reg. 17A(2)] | Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) | No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) | Reason for Cessation | Notes for not providing PAN | Notes for not providing DIN | ||||||||||||||
| 1 | NA | 25-08-2023 | 25-08-2023 | 21.05 | 2 | 2 | 3 | 0 | |||||||||||||||||||
| 2 | NA | 25-08-2023 | 25-08-2023 | 21.05 | 3 | 3 | 3 | 1 | |||||||||||||||||||
| 3 | NA | 25-08-2023 | 25-08-2023 | 21.05 | 3 | 3 | 4 | 1 | |||||||||||||||||||
| 4 | NA | 25-08-2023 | 25-08-2023 | 1 | 0 | 1 | 0 | ||||||||||||||||||||
| 5 | NA | 24-08-2023 | 24-08-2023 | 1 | 0 | 0 | 0 | ||||||||||||||||||||
| 6 | NA | 10-01-2018 | 10-01-2018 | 1 | 0 | 1 | 0 | ||||||||||||||||||||
| 7 | NA | 10-01-2018 | 10-01-2018 | 1 | 0 | 1 | 0 | ||||||||||||||||||||
| 8 | NA | 29-05-2024 | 29-05-2024 | 1 | 0 | 0 | 0 | ||||||||||||||||||||
Text Block | |
| Textual Information(1) | 1. Mr. Prem Sethi is a Whole time Director and COO 2. Three (3) Independent Directors were appointed on 25-08-2023 for a period of 3 years 3. Mr. Kevin Rohitbhai Daftary was re-designated as Nominee Director of Prasid Uno Family Trust w.e.f 27 March, 2025. 4. Mr. Arun Sadhanandham and Ms. Sumona Chakraborty are Nominee Directors of Orbimed Asia III Mauritius Limited. |
Annexure 1 | |||||||
II. Composition of Committees | |||||||
| Disclosure of notes on composition of committees explanatory | Textual Information(1) | ||||||
Annexure 1 Text Block | |
| Textual Information(1) | Internal Finance Committee was constituted on June 26, 2024 Committee of Directors was constiuted on June 18, 2025 |
Audit Committee Details | |||||||
| Whether the Audit Committee has a Regular Chairperson | Yes | ||||||
| Sr | DIN Number | Name of Committee members | Category 1 of directors | Category 2 of directors | Date of Appointment | Date of Cessation | Remarks |
| 1 | 02005378 | SANDHYA GADKARI SHARMA | Non-Executive - Independent Director | Chairperson | 25-08-2023 | ||
| 2 | 08240092 | VASUDEVAN SUJESH | Non-Executive - Independent Director | Member | 25-08-2023 | ||
| 3 | 03504969 | RAJESH SHASHIKANT DALAL | Non-Executive - Independent Director | Member | 25-08-2023 | ||
| 4 | 07466382 | PRABHAT AGRAWAL | Executive Director | Member | 25-08-2023 | ||
Nomination and remuneration committee | |||||||
| Whether the Nomination and remuneration committee has a Regular Chairperson | Yes | ||||||
| Sr | DIN Number | Name of Committee members | Category 1 of directors | Category 2 of directors | Date of Appointment | Date of Cessation | Remarks |
| 1 | 03504969 | RAJESH SHASHIKANT DALAL | Non-Executive - Independent Director | Chairperson | 25-08-2023 | ||
| 2 | 08240092 | VASUDEVAN SUJESH | Non-Executive - Independent Director | Member | 25-08-2023 | ||
| 3 | 08445197 | ARUN SADHANANDHAM | Non-Executive - Nominee Director | Member | 25-08-2023 | ||
Stakeholders Relationship Committee | |||||||
| Whether the Stakeholders Relationship Committee has a Regular Chairperson | Yes | ||||||
| Sr | DIN Number | Name of Committee members | Category 1 of directors | Category 2 of directors | Date of Appointment | Date of Cessation | Remarks |
| 1 | 03504969 | RAJESH SHASHIKANT DALAL | Non-Executive - Independent Director | Chairperson | 25-08-2023 | ||
| 2 | 08445197 | ARUN SADHANANDHAM | Non-Executive - Nominee Director | Member | 25-08-2023 | ||
| 3 | 07077034 | PREM SETHI | Executive Director | Member | 25-08-2023 | ||
Risk Management Committee | |||||||
| Whether the Risk Management Committee has a Regular Chairperson | Yes | ||||||
| Sr | DIN Number | Name of Committee members | Category 1 of directors | Category 2 of directors | Date of Appointment | Date of Cessation | Remarks |
| 1 | 07466382 | PRABHAT AGRAWAL | Executive Director | Chairperson | 25-08-2023 | ||
| 2 | 08445197 | ARUN SADHANANDHAM | Non-Executive - Nominee Director | Member | 25-08-2023 | ||
| 3 | 02005378 | SANDHYA GADKARI SHARMA | Non-Executive - Independent Director | Member | 25-08-2023 | ||
Corporate Social Responsibility Committee | |||||||
| Whether the Corporate Social Responsibility Committee has a Regular Chairperson | |||||||
| Sr | DIN Number | Name of Committee members | Category 1 of directors | Category 2 of directors | Date of Appointment | Date of Cessation | Remarks |
Other Committee | ||||||
| Sr | DIN Number | Name of Committee members | Name of other committee | Category 1 of directors | Category 2 of directors | Remarks |
| 1 | 07466382 | PRABHAT AGRAWAL | Internal Finance Committee | Executive Director | Chairperson | |
| 2 | 08445197 | ARUN SADHANANDHAM | Internal Finance Committee | Non-Executive - Nominee Director | Member | |
| 3 | 10637792 | KEVIN ROHITBHAI DAFTARY | Internal Finance Committee | Non-Executive - Nominee Director | Member | |
| 4 | 07466382 | PRABHAT AGRAWAL | Committee of Directors | Executive Director | Chairperson | |
| 5 | 08240092 | VASUDEVAN SUJESH | Committee of Directors | Non-Executive - Independent Director | Member | |
| 6 | 07077034 | PREM SETHI | Committee of Directors | Executive Director | Member | |
Annexure 1 | ||||||||
Annexure 1 | ||||||||
III. Meeting of Board of Directors | ||||||||
| Disclosure of notes on meeting of board of directors explanatory | ||||||||
| Sr. No. | Date(s) of meeting (if any) in the previous quarter | Date(s) of meeting (if any) in the current quarter | Maximum gap between any two consecutive (in number of days) | Notes for not providing Date | Whether requirement of Quorum met (Yes/No) | Total Number of Directors as on date of the meeting | Number of Directors present* (All directors including Independent Director) | No. of Independent Directors attending the meeting* |
| 1 | 16-01-2025 | Yes | 8 | 8 | 3 | |||
| 2 | 12-02-2025 | 26 | Yes | 8 | 8 | 3 | ||
| 3 | 21-03-2025 | 36 | Yes | 8 | 8 | 3 | ||
| 4 | 27-05-2025 | 66 | Yes | 8 | 8 | 3 | ||
| 5 | 18-06-2025 | 21 | Yes | 8 | 8 | 3 | ||
Annexure 1 | ||||||||||
IV. Meeting of Committees | ||||||||||
| Disclosure of notes on meeting of committees explanatory | ||||||||||
| Sr | Name of Committee | Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) | Maximum gap between any two consecutive (in number of days) | Name of other committee | Reason for not providing date | Whether requirement of Quorum met (Yes/No) | Total Number of Directors in the Committee as on date of the meeting | Number of Directors Present (All Directors including Independent Director) | No. of Independent Directors attending the meeting* | No. of members attending the meeting (other than Board of Directors) |
| 1 | Audit Committee | 12-02-2025 | Yes | 4 | 4 | 3 | 0 | |||
| 2 | Audit Committee | 21-03-2025 | 36 | Yes | 4 | 4 | 3 | 0 | ||
| 3 | Audit Committee | 27-05-2025 | 66 | Yes | 4 | 4 | 3 | 0 | ||
| 4 | Nomination and remuneration committee | 16-01-2025 | Yes | 3 | 3 | 2 | 0 | |||
| 5 | Nomination and remuneration committee | 21-03-2025 | 63 | Yes | 3 | 3 | 2 | 0 | ||
| 6 | Nomination and remuneration committee | 18-06-2025 | 88 | Yes | 3 | 3 | 2 | 0 | ||
Annexure 1 | ||||||||||
IV. Meeting of Committees | ||||||||||
| Sr | Name of Committee | Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) | Maximum gap between any two consecutive (in number of days) | Name of other committee | Reason for not providing date | Whether requirement of Quorum met (Yes/No) | Total Number of Directors in the Committee as on date of the meeting | Number of Directors Present (All Directors including Independent Director) | No. of Independent Directors attending the meeting* | No. of members attending the meeting (other than Board of Directors) |
| 7 | Risk Management Committee | 27-03-2025 | Yes | 3 | 2 | 1 | 0 | |||
| 8 | Other Committee | 12-02-2025 | Internal Finance Committee | Yes | 3 | 3 | 0 | 0 | ||
Annexure 1 | ||
V. Affirmations | ||
| Sr | Subject | Compliance status (Yes/No) |
| 1 | The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 | Yes |
| 2 | The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee | Yes |
| 3 | The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee | Yes |
| 4 | The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee | Yes |
| 5 | The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) | Yes |
| 6 | The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. | Yes |
| 7 | The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. | Yes |
| 8 | This report and/or the report submitted in the previous quarter has been placed before Board of Directors. | Yes |
Annexure 1 | ||
| Sr | Subject | Compliance status |
| 1 | Name of signatory | Ms. Sanu Kapoor |
| 2 | Designation | Company Secretary and Compliance Officer |
Details of Cyber security incidence | ||
| Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter | No | |
| Number of cyber security incidence or breaches or loss of data event occurred during the quarter | ||
| Sr. | Date of the event | Brief details of the event |
Signatory Details | |
| Name of signatory | Ms. Sanu Kapoor |
| Designation of person | Company Secretary and Compliance Officer |
| Place | Mumbai |
| Date | 29-07-2025 |
Investor Grievance Details | |
| No. of investor complaints pending at the beginning of Quarter | 0 |
| No. of investor complaints received during the Quarter | 0 |
| No. of investor complaints disposed off during the Quarter | 0 |
| No. of investor complaints those remaining unresolved at the end of the Quarter | 0 |
Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies- The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below: | |||||
| Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies | |||||
| Sr. No. | Name of the unlisted company in which shares or voting rights have been acquired | Date of acquisition | Aggregate holding (% shares or voting rights) as at the end of the previous quarter | % shares or voting rights acquired during the quarter | Aggregate holding (% shares or voting rights) as at the end of the quarter |
| 1 | Peerless Biotech Private Limited | 05-06-2025 | 60 | 16 | 76 |
| 2 | Ramson Medical Distributors Private Limited | 30-06-2025 | 0 | 70 | 70 |
Disclosure of Imposition of Fine or Penalty The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below: | |||||
| Any Other Information for Disclosure of Imposition of Fine or Penalty | |||||
| Sr. No. | Name of the authority | Nature and details of the action(s) taken or order(s) passed | Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority | Details of the violation(s)/ contravention(s) committed or alleged to be committed | Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible |
| 1 | Bombay Stock Exchange ("BSE") | Fines as per SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (Chapter-VII(A)-Penal Actions for Non-Compliance) | 26-06-2025 | The Annual Secretarial Compliance report pursuant to Regulation 24 A was filed in both pdf and XBRL format within the specified timeline on NSE. However, on BSE the said report was filed in PDF form within timeline but due to technical issue the Company could not upload XBRL format. BSE has imposed a fine of Rs. 50,000 plus GST on the Company for non-submission of XBRL format of the said Report. | The Company has submitted the application to BSE for waiver of the fine imposed for non-submission of the XBRL format within specified timeline. This will not have any impact on its finanacial, operaitonal or other activities |
Disclosure of Updates to Ongoing Tax Litigations or Disputes The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below: | ||||
| Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes | ||||
| Sr. No. | Name of the opposing party | Date of initiation of the litigation / dispute | Status of the litigation / dispute as per last disclosure | Current status of the litigation / dispute |
| 1 | Novacare Healthcare Solutions Private Limited | 21-02-2025 | The Company has filed an appeal before appropriate/appellate authority. The Company does not envisage any material impact on operations or other activities, except for financial impact to the extent of any amount payable against such Demand, if upheld by Appellate Authority | The Company has filed an appeal before appropriate/appellate authority. |